*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : PC3200000
CHEMICAL NAME : Methanol,
((6-(2-(5-nitro-2-furyl)vinyl)-as-triazin-3-yl)imino)
di-
CAS REGISTRY NUMBER : 794-93-4
BEILSTEIN REFERENCE NO. : 0898525
LAST UPDATED : 199612
DATA ITEMS CITED : 19
MOLECULAR FORMULA : C11-H11-N5-O5
MOLECULAR WEIGHT : 293.27
WISWESSER LINE NOTATION : T6NN DNJ CN1Q1Q F1U1- BT5OJ ENW
COMPOUND DESCRIPTOR : Tumorigen
Drug
Mutagen
SYNONYMS/TRADE NAMES :
* 3-Bis(hydroxymethyl)amino-6-(5-nitro-2-furylethenyl)-1,2,4-triazine
* Bis(hydroxymethyl)furatrizine
* 3-Di(hydroxymethyl)amino-6-(2-(5-nitro-2-furyl)vinyl)-1,2,4-triazine
* Dihydroxymethyl furatrizine
* Furatone
* Methanol,
((6-(2-(5-nitro-2-furanyl)ethenyl)-1,2,4-triazin-3-yl)imino)bis-
* N-(6-(5-Nitrofurfurylidenemethyl)-1,2,4-triazin-3-yl)iminodimethanol
* 6-(5-Nitro-2-furylvinyl)-3-(dihydroxydimethylamino)-1,2,4-triazene
* ((6-(2-(5-Nitro-2-furyl)vinyl)-as-triazin-3-yl)imino)dimethanol
* N-(6-(2-(5-Nitro-2-furyl)vinyl)-1,2,4-triazin-3-yl)iminodimethanol
* Panfuran-S
* 1,2,4-Triazine, 3-di(hydroxymethyl)amino-6-(5-nitro-2-furylethenyl)-
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 2690 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PMDCAY Progress in Medical Chemistry. (Elsevier Science Pub. Co., Inc., 52
Vanderbilt Ave., New York, NY 10017) V.1- 1961- Volume(issue)/page/year:
5,320,1967
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1296 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PMDCAY Progress in Medical Chemistry. (Elsevier Science Pub. Co., Inc., 52
Vanderbilt Ave., New York, NY 10017) V.1- 1961- Volume(issue)/page/year:
5,320,1967
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1602 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PMDCAY Progress in Medical Chemistry. (Elsevier Science Pub. Co., Inc., 52
Vanderbilt Ave., New York, NY 10017) V.1- 1961- Volume(issue)/page/year:
5,320,1967
** TUMORIGENIC DATA **
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 25725 mg/kg/35W-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Gastrointestinal - tumors
REFERENCE :
NAIZAM Nara Igaku Zasshi. Journal of the Nara Medical Association. (Nara
Igakkai, c/o Narakenritsu Ika Daigaku, Shijo-cho, Kashihara, Nara-ken,
Japan) V.1- 1950- Volume(issue)/page/year: 31,31,1980
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 12740 mg/kg/35W-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Gastrointestinal - tumors
REFERENCE :
NAIZAM Nara Igaku Zasshi. Journal of the Nara Medical Association. (Nara
Igakkai, c/o Narakenritsu Ika Daigaku, Shijo-cho, Kashihara, Nara-ken,
Japan) V.1- 1950- Volume(issue)/page/year: 31,31,1980
TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 27 gm/kg/36W-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Gastrointestinal - tumors
REFERENCE :
JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60,
1940-78. For publisher information, see JJIND8. Volume(issue)/page/year:
60,1339,1978
TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 27 gm/kg/37W-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Gastrointestinal - tumors
REFERENCE :
IGAYAY Igaku No Ayumi. Progress in Medicine. (Ishiyaku Shuppan K.K.,
1-7-10, Honkomagom, Bunkyo-ku, Tokyo, Japan) V.1- 1946-
Volume(issue)/page/year: 108,96,1979
TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 63210 mg/kg/43W-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Gastrointestinal - tumors
REFERENCE :
EXPADD Experimental Pathology (1981). (Elsevier Scientific Pub. Ireland
Ltd., POB 85, Limerick, Ireland) V.19- 1981- Volume(issue)/page/year:
26,213,1984
** MUTATION DATA **
TYPE OF TEST : Mutation in microorganisms
TEST SYSTEM : Bacteria - Escherichia coli
DOSE/DURATION : 125 ug/L
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 146,243,1985
TYPE OF TEST : DNA repair
TEST SYSTEM : Bacteria - Escherichia coli
DOSE/DURATION : 20 ug/L
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
22,1159,1974
TYPE OF TEST : DNA damage
TEST SYSTEM : Bacteria - Escherichia coli
DOSE/DURATION : 500 ug/L
REFERENCE :
MIIMDV Microbiology and Immunology. (Business Center for Academic Soc.
Japan, 2-4-16 Yayoi, Bunkyo- ku, Tokyo 113, Japan) V.21- 1977-
Volume(issue)/page/year: 21,481,1977
TYPE OF TEST : DNA inhibition
TEST SYSTEM : Bacteria - Escherichia coli
DOSE/DURATION : 500 ug/L
REFERENCE :
MIIMDV Microbiology and Immunology. (Business Center for Academic Soc.
Japan, 2-4-16 Yayoi, Bunkyo- ku, Tokyo 113, Japan) V.21- 1977-
Volume(issue)/page/year: 21,481,1977
TYPE OF TEST : Phage inhibition capacity
TEST SYSTEM : Bacteria - Escherichia coli
DOSE/DURATION : 800 ug/L
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 146,243,1985
TYPE OF TEST : DNA inhibition
TEST SYSTEM : Microorganism - not otherwise specified
DOSE/DURATION : 1 mg/L
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
22,1159,1974
TYPE OF TEST : Mutation test systems - not otherwise specified
TEST SYSTEM : Microorganism - not otherwise specified
DOSE/DURATION : 1 mg/L
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
22,1159,1974
*** REVIEWS ***
IARC Cancer Review:Animal Inadequate Evidence
IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals
to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210)
V.1- 1972- Volume(issue)/page/year: 24,77,1980
IARC Cancer Review:Human No Adequate Data
IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals
to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210)
V.1- 1972- Volume(issue)/page/year: 24,77,1980
IARC Cancer Review:Group 3
IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49
Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year:
7,56,1987
*** STATUS IN U.S. ***
EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat
*** END OF RECORD ***
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
Methanol, (methylnitroamino)-, acetate (ester)
| 36239-01-7 |
Methanol, (methylnitrosoamino)-
| 58840-25-8 |
Methanol,((5-(2-(5-nitro-2-furyl)vinyl)-1,3,4-thiadiazol-2-yl)imino)di-
| 896-04-8 |
Methanol,((6-(2-(5-nitro-2-furyl)vinyl)-as-triazin-3-yl)imino)di-
| 794-93-4 |
Methanol,((nitroimino)bis(methylene(nitroimino)))di-,diacetate (ester)
| 14173-62-7 |
Methanol, (nitrosopropylamino)-
| 86860-63-1 |
Methanol,(1H,3H,5H-oxazolo(3,4-C)oxazol-7a(7H)-ylmethoxy)-
| 59720-42-2 |
Methanol, pentachlorobenzylthio-
| 74037-63-1 |
Methanol, (phenylazo)-, benzoate (ester)
| 63528-74-5 |
Methanol, (phenylphosphinidene)di-
| 3127-08-0 |
Methanesulfinic acid, hydroxy-, monosodium salt
| 149-44-0 |
Methanol, phosphinylidynetri-, cyclic phosphate
| 4726-80-1 |
Methanol, phosphinylidynetri-, cyclic phosphite
| 41097-27-2 |
Methanol, sodium salt
| 124-41-4 |
Methanol, 1,3,4-thiadiazol-2-yliminodi-
| 53532-37-9 |
Methanol, (s-triazine-2,4,6-triyltriimino)tri-
| 1017-56-7 |
Methanol,((s-triazine-2,4,6-triyl)trimethyltrinitrilo)tri-
| 64124-21-6 |
Methanol, (s-triazine-2,4,6-triyltrinitrilo)hexa-
| 531-18-0 |
Methanol,(6-(3,3,3-tribromopropyl)-s-triazine-2,4-diyldinitrilo)tetra-
| 62160-40-1 |
Methanol, triethylsilyl-
| 60764-82-1 |
Methanol, (trimethylsilyl)-
| 3219-63-4 |
Methanesulfinic acid, hydroxy-, monosodium salt,dihydrate
| 6035-47-8 |
Methanol, (trimethylsilyl)-, carbamate
| 3124-45-6 |
Methanol, triphenyl-, thioacetate (ester)
| 74037-64-2 |
Methanol, tris(p-(dimethylamino)phenyl)-
| 467-63-0 |
Methanol, tris(pentafluoroethyl)-
| 6189-00-0 |
4,7-Methano-2,3,8-methenocyclopent(a)indene,dodecahydro-, stereoisomer
| 66289-74-5 |
1,6-Methanonaphthalen-1(2H)-amine, octahydro-
| 60145-64-4 |
1,4-Methanonaphthalene-6,7-dicarboxylic anhydride,1,2,3,4,9,9-hexachloro-5,6,7,8,8a- hexahydro-,(mixture of endo and exo)
| 60145-64-4 |
5,8-Methanonaphthalene,1,4,2,3-diepoxy-5,6,7,8,9,9-hexachloro-1,2,3,4,4a,5,8,8a-octahydro-
| 3212-26-8 |
1,4-Methanonaphthalene-5,8-dione,2,3,6,7-tetrachloro-4a,8a-epoxy-1,2,3,4,4a,8a-hexahydro-
| 4794-20-1 |
1,4-Methanonaphthalene-5,8-dione,1,4,4a,8a-tetrahydro-
| 1200-89-1 |
Methanesulfinic acid,(sulfonylbis(p-phenyleneimino))di-, disodium salt
| 144-75-2 |
5,8-Methanonaphthalene,1,4-epoxy-5,6,7,8,9,9-hexachloro-1,4,4a,5,8,8a-hexahydro-
| 5836-04-4 |
1,4-Methanonaphthalene,1,2,3,4,9,9-hexachloro-1,4,4a,5,6,7,8,8a-octahydro-,chlorinated to contain approximately 72% chloride
| 20757-80-6 |
9,17-Methanonaphtho(2',3'5,6)cyclohept(1,2-d)anthracene-5,10,15,16,18(17H )-pentone,7,8,8a,9-tetrahydro-1,4,6,8,11,14,19-heptahydroxy-2,12-dimethyl-
| 21884-47-9 |
Methanone,(4-((2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl)oxy)-3-methylphenyl) (2-methylphenyl)-
| 83357-08-8 |
Methanone,(4-((2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl)oxy)phenyl)(2-chlorophe nyl)-
| 83357-06-6 |
Methanone,(4-((2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl)oxy)phenyl)(4-nitrophen yl)-, hydrate
| 83357-15-7 |
Methanone,(4-((2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl)oxy)phenyl)(4- (trifluoromethyl)phenyl)-, hemihydrate
| 83366-26-1 |
Methanone,((1-alpha,6-alpha,14-alpha,16-beta)-8-(acetyloxy)-20-ethyl-13-hydroxy-1,6, 16-trimethoxy-4-(methoxymethyl)aconitan-14-yl)(4-methoxyphenyl)-
| 107668-79-1 |
Methanone,(4-((4-aminobenzoyl)oxy)-1-methyl-4-piperidinyl)phenyl-, conjugate monoacid
| 71266-47-2 |
Methanone, (2-amino-5-chlorophenyl)phenyl-
| 719-59-5 |
Methanesulfinothioic acid, S-methyl ester
| 13882-12-7 |
Methanone, (2-amino-5-chlorophenyl)phenyl-,(2,4-dinitrophenyl)hydrazone
| 102996-74-7 |
Methanone,(1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-piperidinyl)(3-methoxyphenyl)-, monomethanesulfonate
| 65189-22-2 |
Methanone, (4-amino-3-hydroxyphenyl)(4-chlorophenyl)-
| 123172-45-2 |
Methanone, (4-amino-3-hydroxyphenyl)phenyl-
| 31684-63-6 |
Methanone, (4-amino-3-hydroxyphenyl)-2-thienyl-
| 54903-55-8 |
Methanone,(3-amino-4-methoxyphenyl)(2,4-dimethoxyphenyl)-
| 75227-00-8 |
|
|